Also of note, Altria announced that between December 2020 and April 2021, Altria’s subsidiaries closed transactions to acquire the remaining 20 percent of the global oral nicotine product on! for a total of approximately $250 million. During the first quarter, Altria’s Helix company expanded the distribution of on! by an additional 15,000 stores. on! achieved a retail share of 1.7 percent in the first quarter, an increase of 0.6 percent from the fourth quarter of 2020.
Total e-vapor category volumes increased by 24 percent versus a year ago while Altria reported that JUUl’s retail share of the total e-vapor category was 33 percent, a decrease of 6 percent year-over-year and 2 percent sequentially. Altria reported a non-cash pre-tax unrealized loss of $200 million as a result of a decrease in the fear value of JUUL, which Altria has a stake in. As of March 31, 2021, the fair value of Altria’s JUUL investment was reported to be $1.5 billion.
Altria re-affirms its guidance for 2021 adjusted diluted EPS to be in a range of $4.49 to $4.62, representing a growth rate of 3-6 percent from an adjusted diluted EPS base of $4.36 in 2020.